Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine.

Andrea Bassi,Vincenzo Piccolo, Alessandro Ginori, Grazia Galippi,Carlo Mazzatenta

Dermatology practical & conceptual(2023)

引用 0|浏览6
暂无评分
摘要
Citation: Bassi A, Piccolo V, Ginori A, Galippi G, Mazzatenta C. Eosinophilic Annular Erythema Due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine. Dermatol Pract Concept. 2023;13(2):e2023095. DOI: https://doi.org/10.5826/dpc.1302a95
更多
查看译文
关键词
certolizumab pegol therapy,rheumatoid arthritis,vaccine,post-covid
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要